Table 5.

Treatment of Manifestations in Individuals with SOX2 Disorder

Manifestation/
Concern
TreatmentConsiderations/Other
DD/ID See Developmental Delay / Intellectual Disability Management Issues.Referral to physiotherapist if evidence of motor impairment
Anophthalmia/
Microphthalmia
Early referral to an experienced multidisciplinary team
  • Prostheses: Consider optically clear expanders to stimulate growth of the orbit & periorbital tissues.
  • Community vision services through early intervention or school district
Anterior pituitary
hypoplasia
Hormone replacement by pediatric endocrinologist
Hypogonadotropic
hypogonadism
Hormone replacement prior to expected onset of puberty by pediatric endocrinologist
Seizures Standardized treatment w/ASM by experienced neurologistEducation of parents/caregivers 1
Spasticity Orthopedist / physical medicine & rehab / PT/OT incl stretching to help avoid contractures & fallsConsider need for positioning & mobility devices & disability parking placard.
Dystonia / Status
dystonicus
PT, hydration, intensive careDystonia may worsen & can show acute change to status dystonicus, which should be considered a medical emergency.
Hearing loss Hearing aids may be helpful per audiologist/otolaryngologist.Community hearing services through early intervention or school district
Esophageal atresia ± tracheoesophageal
fistula
Perinatal surgeryThis constitutes a surgical emergency.

ASM = anti-seizure medication; DD = developmental delay; ID = intellectual disability; OT = occupational therapy; PT = physical therapy

1.

Education of parents/caregivers regarding common seizure presentations is appropriate. For information on nonmedical interventions and coping strategies for children diagnosed with epilepsy, see Epilepsy Foundation Toolbox.

From: SOX2 Disorder

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.